For all health plans, increasing complexity requires rethinking the presentation of options to members. Choice design, stepped information reveal, high quality, and timely communication, are keys to providing members a helpful and trustworthy healthcare GPS.
FDA approved a new treatment for non-small cell lung cancer, as well as drugs to treat chronic immune thrombocytopenia and a rare form of childhood rickets.
A new program shows promise for improving patient medication adherence. Find out how it works.
A call center-based social support role may be a valuable addition to the evolving healthcare workforce, according to a new study.
Oncology experts shed light on progress of genetic testing and targeted therapies in lung cancer.
Hospitals who have deployed a smartphone-based communications platform, surveyed by Spyglass Consulting Group identified five forward-looking opportunities to expand their existing deployments.
Here are five strategies managed care organizations and healthcare providers can use to support chronic patients and improve the efficiency and effectiveness of chronic care.
Chronic obstructive pulmonary disease (COPD) affects women differently than men. Here are some of the biggest variations.
CEO of a Pennsylvania-based oncology group shares how participating in a new value-based model is changing the care approach.
A new CAQH CORE report has the inside information to streamline the exchange of value-based payment information.
FDA is permitting marketing of the first medical device that uses artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy.
FDA approved a new indication for Exparel Bupivacaine Liposome injectable suspension (Exparel, Pacira) for use as a nerve block to produce post-surgical regional analgesia following shoulder surgery in adults.
A new survey from PNC Healthcare sheds important light on patient-centered care among various age groups, especially millennials.
How Humana is successfully improving care for members in two cities.
Here are three innovative structures in pricing models to address the high-cost of curative therapies.
A new study looks at how U.S. healthcare spending compares to 10 other high-income countries. Here are three of the biggest areas in which U.S. spending is higher.
Here's how one federally qualified health center in southcentral Pennsylvania is tackling the opioid crisis in its community.
HealthKonnect, a subsidiary of Chinese insurer Ping An Insurance Group developed a personal health-risk prediction model that has the ability to predict at individual patient level future healthcare risks measured by total medical costs. Here’s how.
Attending the AMCP Managed Care and Specialty Pharmacy Annual Meeting in Boston April 23 to April 26? Here are our top session recommendations.
A study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
After US Surgeon General Jerome M. Adams, MD, MPH, urged more Americans to carry naloxone to reverse opioid overdoses, organizations and medical experts praised the decision.
A new Private Exchange Research Council study shows why decision support and educational tools are necessary to help employees navigate the choice in benefits.
Healthcare systems stand to lose $6 million if burned out physicians choose to resign or work elsewhere. Here are some ways to curb burnout and its associated costs.
A new deal between pharma giants AbbVie and Samsung Bioepis is designed to postpone competition against a biosimilar to Humira until 2023.
HealthPartners’ vice president and associate medical director shares how the integrated organization is looking beyond traditional approaches to curb diabetes.
In the shift to value care, value-based purchasing guidelines reward positive quality metrics with bonuses and levy fines and assessments on institutions that are unable to demonstrate quality of care. Often however, it’s not the care itself that’s at fault, but the reporting. Here’s an approach to capturing those crucial metrics.
Successful health systems share their tips.
Diabetes drug spending is on the rise, but there are ways to control it.
Experts weigh in on the spending outlook for these high-cost conditions.
Gene therapy is leaving its mark, while payers contemplate payment models, value, and efficacy issues.
